Pitson G, Fyles A, Milosevic M, Wylie J, Pintilie M, Hill R
Department of Radiation Oncology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada.
Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):699-703. doi: 10.1016/s0360-3016(01)01662-5.
To determine the relationships between tumor oxygenation and nodal stage in a prospective study of patients with cervix cancer, controlling for other prognostic factors.
Between 1994 and 1999, 128 eligible patients with cervix cancer were entered into a prospective study of tumor oxygenation assessed by Eppendorf oxygen electrode before primary radiation therapy. Oxygenation was evaluated using the proportion of pO(2) values < 5 mmHg (HP(5)), and tumors were classified as hypoxic if the HP(5) was > 50%. Patients were assigned to one of three groups: those with no imaging evidence of nodal (pelvic or para-aortic) or distant metastatic disease (N group; n = 67), those with equivocal findings (E group; n = 28), and those with nodal or distant metastatic disease (P group; n = 33).
The proportion of hypoxic tumors in the P, E, and N groups were 67%, 50%, and 40%, respectively (p = 0.014), with median HP(5) values of 63%, 48%, and 36%, respectively (p = 0.0024). In a multivariate analysis including tumor size, stage, HP(5), and hemoglobin, it was found that tumor size and HP(5) were the only independently significant variables for the finding of metastatic disease (p = 0.009 and 0.017, respectively).
In this patient population, there was a significantly increased risk of nodal or distant metastases in patients with hypoxic tumors, and this finding was independent of tumor size. These results are consistent with the hypothesis that tumor hypoxia is an adverse prognostic factor associated with selection for a metastatic phenotype.
在一项针对宫颈癌患者的前瞻性研究中,控制其他预后因素,确定肿瘤氧合与淋巴结分期之间的关系。
1994年至1999年间,128例符合条件的宫颈癌患者进入一项前瞻性研究,在初次放射治疗前通过Eppendorf氧电极评估肿瘤氧合情况。使用pO(2)值<5 mmHg(HP(5))的比例来评估氧合情况,如果HP(5)>50%,则肿瘤被分类为缺氧。患者被分为三组之一:无淋巴结(盆腔或腹主动脉旁)或远处转移疾病影像学证据的患者(N组;n = 67)、检查结果不明确的患者(E组;n = 28)和有淋巴结或远处转移疾病的患者(P组;n = 33)。
P组、E组和N组中缺氧肿瘤的比例分别为67%、50%和40%(p = 0.014),HP(5)中位数分别为63%、48%和36%(p = 0.0024)。在一项包括肿瘤大小、分期、HP(5)和血红蛋白的多变量分析中,发现肿瘤大小和HP(5)是发现转移疾病的仅有的独立显著变量(分别为p = 0.009和0.017)。
在该患者群体中,缺氧肿瘤患者发生淋巴结或远处转移的风险显著增加,且这一发现与肿瘤大小无关。这些结果与肿瘤缺氧是与转移表型选择相关的不良预后因素这一假设一致。